Bariatric surgery as urate-lowering therapy in severe obesity
The emerging problem of biological treatment in migrant and travelling populations : it is time to extend guidelines for the screening of infectious diseases
Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes : a prospective longitudinal study
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis : the ACT-RAY study
The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis : results from the ACT-RAY MRI substudy
Ustekinumab for the treatment of patients with active ankylosing spondylitis : results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis : data from the Osteoarthritis Initiative
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis : results at week 24
Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies
What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review
Safety profile of protein kinase inhibitors in rheumatoid arthritis : systematic review and meta-analysis
The relationship between longitudinal serum leptin measures and measures of magnetic resonance imaging-assessed knee joint damage in a population of mid-life women
Genetics of toll like receptor 9 in ANCA associated vasculitides
FMF50 : a score for assessing outcome in familial Mediterranean fever
Development of patient-centred standards of care for rheumatoid arthritis in Europe : the eumusc.net project
Development of healthcare quality indicators for rheumatoid arthritis in Europe : the eumusc.net project
Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers : a mechanistic study with 12 months follow-up
Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis
Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis
Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort : a Mendelian randomisation approach
Fibrosis biomarkers in isolated Raynaud's phenomenon : too little, too soon?
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients
Use of statins is associated with a lower prevalence of generalised osteoarthritis
Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab : implications for molecular targeted therapy
Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour
Retraction
When is it not ethical to withhold treatment for rheumatoid arthritis?
Response to : ‘When is it not ethical to withhold treatment for rheumatoid arthritis?’ by Dr Yusuf Yazici
The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis : comment on ‘Cardiovascular comorbidities in patients with psoriatic arthritis
Response to : ‘The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis’ by González-Gay et al
Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?
Response to : ‘Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?’ by Jan Damoiseaux